Getinge Industrier S (GNGBF) 25.1000 $GNGBF
Global Market Study on HAIs Control: Cleaning and Sterilization to Witness Highest Growth by 2020
M2 - Fri Jul 10, 5:30AM CDT
Research and Markets (http://www.researchandmarkets.com/research/dpdmf2/global_market) has announced the addition of the "Global Market Study on HAIs Control: Cleaning and Sterilization to Witness Highest Growth by 2020" report to their offering. The global HAIs control market is estimated at USD 50,807.0 million in 2014. It is likely to grow with a CAGR of 8.5% and reach USD 82,889.4 million in 2020. Hospital-acquired infections (HAIs), also known as nosocomial infections, refer to infections that are acquired by patients during their stay in hospitals. Globally, the HAIs control market is witnessing significant growth due to high prevalence of various hospital infections and increasing aging population. In addition, rising number of initiatives undertaken by government and nongovernment organizations and hot and humid environmental conditions are driving the HAIs control market. However, factors such as lack of primary healthcare facilities and infrastructure and limited awareness about HAIs in developing regions are restraining the global market for HAIs control. Increasing popularity of gas plasma sterilization technology is one of the major trends that have been observed in the HAIs control market. North America has the largest market for the HAIs control market. North America market for HAIs control is estimated at USD 21,319.2 million in 2014 and is expected to reach USD 34,430.3 million in 2020, growing at a CAGR of 8.3%. Diagnostic techniques are the largest segment in the overall HAIs control market. In terms of diseases, pneumonia is the largest segment. In terms of growth, Asia is the fastest growing region, cleaning and sterilization is the fastest growing segment and primary bloodstream infections are the fastest growing type of HAIs. STERIS Corporation is a leading player for cleaning and sterilization in the overall HAIs control market, with a share of about 25% of the cleaning and sterilization market in 2013. Getinge AB accounts for about 24% of the global cleaning and sterilization market for HAIs control. Some of the other major players in HAIs control market are Advanced Sterilization Products Division Ethicon US, LLC, Cepheid, Pfizer, Inc, Hoffmann-La Roche, Ltd., Becton, Dickinson and Company and Kimberly-Clark Corporation. Key Topics Covered: Chapter 1 Preface Chapter 2 Market Synopsis Chapter 3 Porter's Five Forces Analysis Chapter 4 Market Overview Chapter 5 Global Market Size and Forecast Chapter 6 Market Size and Forecast by Cleaning and Sterilization Chapter 7 Market Size and Forecast by Diagnostic Techniques Chapter 8 Market Size and Forecast by Treatment Chapter 9 Market Size and Forecast by Disease Chapter 10 Market Size and Forecast by Geography Chapter 11 Competitive Scenario Chapter 12 Company Profiles - Advanced Sterilization Products Division Ethicon US, LLC - Becton, Dickinson and Company - bioMerieux SA - Cantel Medical - Cepheid - Getinge AB - Hoffmann-La Roche, Ltd. - Kimberly-Clark Corporation - Merck & Co., Inc. - Pfizer, Inc. - STERIS Corporation For more information visit http://www.researchandmarkets.com/research/dp...bal_market
STE: 66.55 (+1.47), PFE: 34.36 (+0.50), MRK: 57.95 (+0.57), KMB: 109.72 (+1.02), CPHD: 58.15 (+0.75), CMN: 54.71 (+1.79)
Gamma Medica Bolsters Executive Team to Support the Fight Against Breast Cancer with Focus on Growth and Commercialization of Molecular Breast Imaging
Business Wire - Mon Jun 08, 8:05AM CDT
Gamma Medica, a leader in molecular breast imaging (MBI) technology, announced today that Philip M. Croxford has been appointed as Chief Executive Officer. The Company also named Scott Headland as its new Vice President of Sales. These executive changes align with Gamma Medica's focus on commercializing its unique breast imaging technology for improved cancer detection in the 40 percent of women with dense breast tissue. Gamma Medica's former CEO, Jim Calandra, has left the company to pursue other business opportunities.
JNJ: 99.53 (+1.13)
Global Fetal Monitoring Market Report 2015-2019 - Product, Portability, Method, Application, End User Analysis
M2 - Wed Apr 29, 5:01AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hjxz32/fetal_monitoring) has announced the addition of the "Fetal Monitoring Market by Product (Ultrasound, Electronic Fetal Monitors, Electrodes, Doppler, Uterine Contraction, Telemetry), Portability, Method (Invasive), Application (Antepartum, Intrapartum), End User (Hospital, Clinics) - Forecast to 2019" report to their offering. The fetal monitoring market is expected to reach $2,346.4 million by 2019 from $1,688.7 million in 2014, at a CAGR of 6.8%. This market is segmented based on products, portability, methods, applications, end users, and geography. Based on products, the fetal monitoring market is segmented into instruments and consumables, and software. The instruments and consumables segment includes ultrasound, electronic fetal monitors, fetal electrodes, fetal Doppler, uterine contraction monitors, telemetry solutions, accessories and consumables, and other products. Instruments and consumables accounted for the largest share of the market, primarily due to the increasing rate of maternal mortality and birth defects. In addition, increasing investments by government organizations to improve prenatal care, coupled with technological advancements, will further enhance the growth of this market. Based on portability, the fetal monitoring market is segmented into portable and non-portable systems. The non-portable systems segment accounted for the largest share of the market. Increasing initiatives by companies to develop new and advanced equipment will drive the growth of this market. Based on method, the fetal monitoring market is segmented into invasive and non-invasive methods. The non-invasive segment accounted for the largest share of this market. Growth in this segment can be attributed to the rising awareness of maternal/fetal care and increasing government and non-government initiatives to prevent maternal mortality across the globe. Based on application, the fetal monitoring market is segmented into antepartum and intrapartum. The antepartum segment accounted for the largest share of the market. Rising incidences of congenital anomalies and development of new products by companies will drive the growth of this market. Based on end users, the fetal monitoring market is segmented into hospitals, clinics, and others. The hospitals segment is the major end-user segment in this market. Increasing initiatives by government and non-government organizations to provide improved prenatal care facilities will drive the growth in this segment. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Fetal Monitoring Market, By Product 8 Fetal Monitoring Market, By Portability 9 Fetal Monitoring Market, By Method 10 Fetal Monitoring Market, By Application 11 Fetal Monitoring Market, By End User 12 Global Fetal Monitoring Market, By Region 13 Competitive Landscape 14 Company Profiles - Analogic Corporation - Arjohuntleigh (Subsidiary of Getinge AB) - Covidien PLC (Wholly-Owned Subsidiary of Medtronic PLC) - Fujifilm Sonosite, Inc. (A Fully Owned Subsidiary of Fujifilm Holdings Corporation) - Ge Healthcare (A Fully Owned Subsidiary of General Electric Company) - Natus Medical Incorporated - Neoventa Medical AB - Philips Healthcare (A Subsidiary of Royal Philips Electronics) - Siemens Healthcare (Subsidiary of Siemens Ag) - Spacelabs Healthcare (Subsidiary of OSI Systems) For more information visit http://www.researchandmarkets.com/research/hj...monitoring
BABY: 42.30 (+1.11), GE: 26.27 (+0.25), PHG: 26.26 (+1.11), MDT: 74.37 (+1.28), ALOG: 77.61 (+1.89), OSIS: 71.42 (+1.63)
Getinge swings to profit in January to March 2015 quarter
M2 - Tue Apr 21, 3:49AM CDT
Swedish healthcare company Getinge AB (STO: GETIB) on Monday reported net profit of SEK107m, or EPS of SEK0.38, for the quarter January 2015 to March 2105.
Getinge reports on AGM 2015 resolutions
M2 - Thu Mar 26, 5:02AM CDT
Medical technology company Getinge AB (STO:GETIB) announced on Wednesday that at the Annual General Meeting held on 25 March 2015, Carl Bennet (chairman), Johan Bygge, Cecilia Daun Wennborg, Carola Lemne, Malin Persson, Johan Stern and Maths Wahlstrom were re-elected as members of the board of directors.
Getinge Group: Resolutions at Getinge's Annual General Meeting
Business Wire - Wed Mar 25, 12:08PM CDT
Regulatory News:
Leading 100 Global Medical Supplies Companies 2015
M2 - Mon Mar 23, 10:39AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9tqljh/global_medical) has announced the addition of the "Global Medical Supplies 100 - An Industry Report" report to their offering. Global demand for disposable medical supplies is projected to grow 6.4 percent annually to nearly $200 billion in 2016. The range of disposable medical supplies consumed worldwide extends into 11 major product segments and eight additional product lines. Among the major product segments, world demand in 2016 will range from $7.5 billion for patient room supplies to $32.2 billion for surgical instruments and supplies. The medical supplies industry is essentially a growth industry. Value line divides the group into medical supplies invasive and medical supplies non invasive. Affordability by patients, increased awareness on health care, improved hospital infrastructure, and the increased disease patterns are listed as the primary drivers boosting the growth of medical equipment and supplies industry. Free market environment, a developed industry, and investment in health infrastructure are amongst other factors that enhance the growth of high quality medical equipments and supplies industry. Report Highlights: - Leading 100 medical supplies companies globally - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances among leading global medical supplies companies - International presence of global medical supplies companies - R&D activities by global medical supplies companies Key Topics Covered: 1: Rankings of Medical Supplies Companies Globally 1.1: Leading 100 Medical Supplies Companies Globally (based on recent sales, net income, total assets, total equity) 1.2: Most Growing 25 Medical Supplies Companies Globally 1.3: Most Profitable 25 Medical Supplies Companies Globally 2: Stock Market Performance over 5 Years: Leading 25 Medical Supplies Companies Globally 3: Key News of Medical Supplies Sector Globally for Year 2014 3.1 - Key Company News: By Country and Company 3.2 - Key Company News: By News Category 3.3 - Key Industry News: By News Category 4: Important Alliances among Leading Medical Supplies Companies Globally 5: International Presence of Global Medical Supplies Companies 6: Research and Development Activities by Global Medical Supplies Companies 7: Mergers and Acquisitions among Global Medical Supplies Companies Companies Mentioned (Partial List) - 3M Company (United States) - Angiodynamics, Inc. (United States) - Baxter International Inc. (United States) - C R Bard Inc (United States) - Carefusion Corporation (United States) - Coloplast AS (Denmark) - Cooper Companies Inc (United States) - Covidien Plc (Ireland) - Elekta publ AB (United States) - Essilor International Compagnie Generale D'optique Sa (Sweden) - Getinge AB (France) - Hartalega Holdings Bhd (Sweden) - Koninklijke Philips NV (Malaysia) - Medcomtech SA (Netherlands) - Nitto Denko (Spain) - Ossur hf. (Iceland) - Otsuka Pharmaceutical Co., Ltd. (Japan) - Prim, S.A. (Spain) - Sonova Holding AG (Switzerland) - William Demant Holding (Denmark) - Ypsomed Holding AG (Switzerland) For more information visit http://www.researchandmarkets.com/research/9t...al_medical
MMM: 154.95 (+1.20), BAX: 37.61 (+0.59), COO: 176.12 (+1.44)
Notice of Annual General Meeting in Getinge AB
Business Wire - Thu Feb 19, 5:26AM CST
Regulatory News:
Macrocure elects Mark Page as CFO
M2 - Mon Feb 09, 6:24AM CST
Biopharmaceutical company Macrocure (NasdaqGM:MCUR) revealed on Monday that it has appointed Mark Page as its chief financial officer effective 10 February 12015.
MCUR: 12.17 (-0.98)
Macrocure Hires Mark Page as Chief Financial Officer
GlobeNewswire - Mon Feb 09, 3:04AM CST
Macrocure Ltd. (Nasdaq:MCUR), a clinical-stage biopharmaceutical company focused on developing a novel therapeutic platform to address chronic and hard-to-heal wounds, today announced that Mark Page, a Managing Director at Credit Suisse in New York, will join Macrocure as Chief Financial Officer effective February 10, 2015.
JNJ: 99.53 (+1.13), MCUR: 12.17 (-0.98), DHR: 86.65 (+0.91)
Getinge - A Restructuring Play
Jan Martinek - at Seeking Alpha - Wed Feb 04, 9:02AM CST
Getinge Group Year-End Report 2014
Business Wire - Wed Jan 28, 7:24AM CST
Regulatory News:
Sterilization Technologies - A 2015 Global Market Overview of the $9.5 Billion Market
M2 - Wed Jan 21, 5:35AM CST
Research and Markets (http://www.researchandmarkets.com/research/4j5x5l/sterilization) has announced the addition of the "Sterilization Technologies - A Global Market Overview" report to their offering. Global sterilization market is expected to touch US$5.3 billion 2015 and projected to touch US$9.5 billion in 2020, growing by a CAGR of 12% between 2014 and 2020. Filtration estimated the leading technology for sterilization in 2014 with US$2.7 billion and expected to touch US$3.1 billion 2015 while Medical Devices is the largest application area with market worth US$3 billion in 2014. Growing and aging global population has led to more and more surgeries being performed today than ever before. Therefore, maintaining patient safety assumes extreme criticality in the field of surgery and rules and regulations have to be in place for every aspect of the process for ensuring that errors are averted at all costs. As a consequence, disinfection and sterilization of surgical instruments becomes one area of crucial significance for upholding patient safety. This factor has a direct correlation with an increase in demand for sterilization equipment. Given the fact that every hospital and healthcare facility gives paramount importance to patient safety, sterilization techniques are most widely utilized for medical device applications. This report reviews, analyses and projects the Sterilization technologies market for global and the regional markets including the United States, Europe, Asia-Pacific and Rest of World. Global market for sterilization technologies is projected to touch $9.5 billion by 2020 growing at a decent rate compounded annually at 12% for the period 2014-2020. The United States leads the global market with a share of 29% closely followed by Europe with 27%, during 2014-2020, converting to US$1.4 billion and 1.3 billion respectively in 2014. Worldwide market for sterilization technologies explored in this study includes Chemical Sterilization, Heat Sterilization, Filtration Sterilization and Radiation Sterilization. The report also analyzes the market by application comprising Medical Devices, Pharmaceuticals, Life Sciences and Others. The global market for the above mentioned technologies and applications is analyzed in terms of USD. Key Topics Covered: Part A: Global Market Perspective 1. Introduction 2. Sterilization Applications - A Snapshot 3. Key Market Trends 4. Key Global Players 5. Key Business Trends 6. Global Market Overview Part B: Regional Market Perspective Regional Market Overview 1. The United States 2. Europe 3. Asia-Pacific 4. Rest Of World Part C: Guide To The Industry 1. North America 2. Europe 3. Asia-Pacific 4. Rest Of World Part
Annexure 1. Research Methodology 2. Feedback Executive Summary: - 3M Company - Advanced Sterilization Products - Andersen Products, Inc. - Baumer SA - Belimed AG - Cantel Medical Corp. - Getinge AB - Medline Industries, Inc - Nordion, Inc. - Sakura Seiki Co Ltd - Sterigenics International Inc. - Sterile Technologies, Inc. - Steris Corporation - Synergy Health Plc - TSO3 Inc. - Tuttnauer USA Co Ltd For more information visit http://www.researchandmarkets.com/research/4j...rilization
MMM: 154.95 (+1.20), CMN: 54.71 (+1.79)
Getinge: Share Decline On CEO Resignation Presents A Buying Opportunity
Jan Martinek - at Seeking Alpha - Thu Jan 15, 12:33PM CST
Getinge names Alex Myers as new President and CEO
M2 - Tue Jan 13, 4:39AM CST
Medical technology company Getinge AB (STO:GETIB) announced on Monday the appointment of Alex Myers as new president and CEO of the Getinge Group.
Alex Myers Appointed New President and CEO of the Getinge Group
Business Wire - Mon Jan 12, 6:19AM CST
Regulatory News:
Global Market Study on HAIs Control: Cleaning and Sterilization to Witness Highest Growth by 2020
M2 - Fri Jul 10, 5:30AM CDT
Research and Markets (http://www.researchandmarkets.com/research/dpdmf2/global_market) has announced the addition of the "Global Market Study on HAIs Control: Cleaning and Sterilization to Witness Highest Growth by 2020" report to their offering. The global HAIs control market is estimated at USD 50,807.0 million in 2014. It is likely to grow with a CAGR of 8.5% and reach USD 82,889.4 million in 2020. Hospital-acquired infections (HAIs), also known as nosocomial infections, refer to infections that are acquired by patients during their stay in hospitals. Globally, the HAIs control market is witnessing significant growth due to high prevalence of various hospital infections and increasing aging population. In addition, rising number of initiatives undertaken by government and nongovernment organizations and hot and humid environmental conditions are driving the HAIs control market. However, factors such as lack of primary healthcare facilities and infrastructure and limited awareness about HAIs in developing regions are restraining the global market for HAIs control. Increasing popularity of gas plasma sterilization technology is one of the major trends that have been observed in the HAIs control market. North America has the largest market for the HAIs control market. North America market for HAIs control is estimated at USD 21,319.2 million in 2014 and is expected to reach USD 34,430.3 million in 2020, growing at a CAGR of 8.3%. Diagnostic techniques are the largest segment in the overall HAIs control market. In terms of diseases, pneumonia is the largest segment. In terms of growth, Asia is the fastest growing region, cleaning and sterilization is the fastest growing segment and primary bloodstream infections are the fastest growing type of HAIs. STERIS Corporation is a leading player for cleaning and sterilization in the overall HAIs control market, with a share of about 25% of the cleaning and sterilization market in 2013. Getinge AB accounts for about 24% of the global cleaning and sterilization market for HAIs control. Some of the other major players in HAIs control market are Advanced Sterilization Products Division Ethicon US, LLC, Cepheid, Pfizer, Inc, Hoffmann-La Roche, Ltd., Becton, Dickinson and Company and Kimberly-Clark Corporation. Key Topics Covered: Chapter 1 Preface Chapter 2 Market Synopsis Chapter 3 Porter's Five Forces Analysis Chapter 4 Market Overview Chapter 5 Global Market Size and Forecast Chapter 6 Market Size and Forecast by Cleaning and Sterilization Chapter 7 Market Size and Forecast by Diagnostic Techniques Chapter 8 Market Size and Forecast by Treatment Chapter 9 Market Size and Forecast by Disease Chapter 10 Market Size and Forecast by Geography Chapter 11 Competitive Scenario Chapter 12 Company Profiles - Advanced Sterilization Products Division Ethicon US, LLC - Becton, Dickinson and Company - bioMerieux SA - Cantel Medical - Cepheid - Getinge AB - Hoffmann-La Roche, Ltd. - Kimberly-Clark Corporation - Merck & Co., Inc. - Pfizer, Inc. - STERIS Corporation For more information visit http://www.researchandmarkets.com/research/dp...bal_market
STE: 66.55 (+1.47), PFE: 34.36 (+0.50), MRK: 57.95 (+0.57), KMB: 109.72 (+1.02), CPHD: 58.15 (+0.75), CMN: 54.71 (+1.79)
Gamma Medica Bolsters Executive Team to Support the Fight Against Breast Cancer with Focus on Growth and Commercialization of Molecular Breast Imaging
Business Wire - Mon Jun 08, 8:05AM CDT
Gamma Medica, a leader in molecular breast imaging (MBI) technology, announced today that Philip M. Croxford has been appointed as Chief Executive Officer. The Company also named Scott Headland as its new Vice President of Sales. These executive changes align with Gamma Medica's focus on commercializing its unique breast imaging technology for improved cancer detection in the 40 percent of women with dense breast tissue. Gamma Medica's former CEO, Jim Calandra, has left the company to pursue other business opportunities.
JNJ: 99.53 (+1.13)
Global Fetal Monitoring Market Report 2015-2019 - Product, Portability, Method, Application, End User Analysis
M2 - Wed Apr 29, 5:01AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hjxz32/fetal_monitoring) has announced the addition of the "Fetal Monitoring Market by Product (Ultrasound, Electronic Fetal Monitors, Electrodes, Doppler, Uterine Contraction, Telemetry), Portability, Method (Invasive), Application (Antepartum, Intrapartum), End User (Hospital, Clinics) - Forecast to 2019" report to their offering. The fetal monitoring market is expected to reach $2,346.4 million by 2019 from $1,688.7 million in 2014, at a CAGR of 6.8%. This market is segmented based on products, portability, methods, applications, end users, and geography. Based on products, the fetal monitoring market is segmented into instruments and consumables, and software. The instruments and consumables segment includes ultrasound, electronic fetal monitors, fetal electrodes, fetal Doppler, uterine contraction monitors, telemetry solutions, accessories and consumables, and other products. Instruments and consumables accounted for the largest share of the market, primarily due to the increasing rate of maternal mortality and birth defects. In addition, increasing investments by government organizations to improve prenatal care, coupled with technological advancements, will further enhance the growth of this market. Based on portability, the fetal monitoring market is segmented into portable and non-portable systems. The non-portable systems segment accounted for the largest share of the market. Increasing initiatives by companies to develop new and advanced equipment will drive the growth of this market. Based on method, the fetal monitoring market is segmented into invasive and non-invasive methods. The non-invasive segment accounted for the largest share of this market. Growth in this segment can be attributed to the rising awareness of maternal/fetal care and increasing government and non-government initiatives to prevent maternal mortality across the globe. Based on application, the fetal monitoring market is segmented into antepartum and intrapartum. The antepartum segment accounted for the largest share of the market. Rising incidences of congenital anomalies and development of new products by companies will drive the growth of this market. Based on end users, the fetal monitoring market is segmented into hospitals, clinics, and others. The hospitals segment is the major end-user segment in this market. Increasing initiatives by government and non-government organizations to provide improved prenatal care facilities will drive the growth in this segment. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Fetal Monitoring Market, By Product 8 Fetal Monitoring Market, By Portability 9 Fetal Monitoring Market, By Method 10 Fetal Monitoring Market, By Application 11 Fetal Monitoring Market, By End User 12 Global Fetal Monitoring Market, By Region 13 Competitive Landscape 14 Company Profiles - Analogic Corporation - Arjohuntleigh (Subsidiary of Getinge AB) - Covidien PLC (Wholly-Owned Subsidiary of Medtronic PLC) - Fujifilm Sonosite, Inc. (A Fully Owned Subsidiary of Fujifilm Holdings Corporation) - Ge Healthcare (A Fully Owned Subsidiary of General Electric Company) - Natus Medical Incorporated - Neoventa Medical AB - Philips Healthcare (A Subsidiary of Royal Philips Electronics) - Siemens Healthcare (Subsidiary of Siemens Ag) - Spacelabs Healthcare (Subsidiary of OSI Systems) For more information visit http://www.researchandmarkets.com/research/hj...monitoring
BABY: 42.30 (+1.11), GE: 26.27 (+0.25), PHG: 26.26 (+1.11), MDT: 74.37 (+1.28), ALOG: 77.61 (+1.89), OSIS: 71.42 (+1.63)
Getinge swings to profit in January to March 2015 quarter
M2 - Tue Apr 21, 3:49AM CDT
Swedish healthcare company Getinge AB (STO: GETIB) on Monday reported net profit of SEK107m, or EPS of SEK0.38, for the quarter January 2015 to March 2105.
Getinge reports on AGM 2015 resolutions
M2 - Thu Mar 26, 5:02AM CDT
Medical technology company Getinge AB (STO:GETIB) announced on Wednesday that at the Annual General Meeting held on 25 March 2015, Carl Bennet (chairman), Johan Bygge, Cecilia Daun Wennborg, Carola Lemne, Malin Persson, Johan Stern and Maths Wahlstrom were re-elected as members of the board of directors.
Getinge Group: Resolutions at Getinge's Annual General Meeting
Business Wire - Wed Mar 25, 12:08PM CDT
Regulatory News:
Leading 100 Global Medical Supplies Companies 2015
M2 - Mon Mar 23, 10:39AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9tqljh/global_medical) has announced the addition of the "Global Medical Supplies 100 - An Industry Report" report to their offering. Global demand for disposable medical supplies is projected to grow 6.4 percent annually to nearly $200 billion in 2016. The range of disposable medical supplies consumed worldwide extends into 11 major product segments and eight additional product lines. Among the major product segments, world demand in 2016 will range from $7.5 billion for patient room supplies to $32.2 billion for surgical instruments and supplies. The medical supplies industry is essentially a growth industry. Value line divides the group into medical supplies invasive and medical supplies non invasive. Affordability by patients, increased awareness on health care, improved hospital infrastructure, and the increased disease patterns are listed as the primary drivers boosting the growth of medical equipment and supplies industry. Free market environment, a developed industry, and investment in health infrastructure are amongst other factors that enhance the growth of high quality medical equipments and supplies industry. Report Highlights: - Leading 100 medical supplies companies globally - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances among leading global medical supplies companies - International presence of global medical supplies companies - R&D activities by global medical supplies companies Key Topics Covered: 1: Rankings of Medical Supplies Companies Globally 1.1: Leading 100 Medical Supplies Companies Globally (based on recent sales, net income, total assets, total equity) 1.2: Most Growing 25 Medical Supplies Companies Globally 1.3: Most Profitable 25 Medical Supplies Companies Globally 2: Stock Market Performance over 5 Years: Leading 25 Medical Supplies Companies Globally 3: Key News of Medical Supplies Sector Globally for Year 2014 3.1 - Key Company News: By Country and Company 3.2 - Key Company News: By News Category 3.3 - Key Industry News: By News Category 4: Important Alliances among Leading Medical Supplies Companies Globally 5: International Presence of Global Medical Supplies Companies 6: Research and Development Activities by Global Medical Supplies Companies 7: Mergers and Acquisitions among Global Medical Supplies Companies Companies Mentioned (Partial List) - 3M Company (United States) - Angiodynamics, Inc. (United States) - Baxter International Inc. (United States) - C R Bard Inc (United States) - Carefusion Corporation (United States) - Coloplast AS (Denmark) - Cooper Companies Inc (United States) - Covidien Plc (Ireland) - Elekta publ AB (United States) - Essilor International Compagnie Generale D'optique Sa (Sweden) - Getinge AB (France) - Hartalega Holdings Bhd (Sweden) - Koninklijke Philips NV (Malaysia) - Medcomtech SA (Netherlands) - Nitto Denko (Spain) - Ossur hf. (Iceland) - Otsuka Pharmaceutical Co., Ltd. (Japan) - Prim, S.A. (Spain) - Sonova Holding AG (Switzerland) - William Demant Holding (Denmark) - Ypsomed Holding AG (Switzerland) For more information visit http://www.researchandmarkets.com/research/9t...al_medical
MMM: 154.95 (+1.20), BAX: 37.61 (+0.59), COO: 176.12 (+1.44)
Notice of Annual General Meeting in Getinge AB
Business Wire - Thu Feb 19, 5:26AM CST
Regulatory News:
Macrocure elects Mark Page as CFO
M2 - Mon Feb 09, 6:24AM CST
Biopharmaceutical company Macrocure (NasdaqGM:MCUR) revealed on Monday that it has appointed Mark Page as its chief financial officer effective 10 February 12015.
MCUR: 12.17 (-0.98)
Macrocure Hires Mark Page as Chief Financial Officer
GlobeNewswire - Mon Feb 09, 3:04AM CST
Macrocure Ltd. (Nasdaq:MCUR), a clinical-stage biopharmaceutical company focused on developing a novel therapeutic platform to address chronic and hard-to-heal wounds, today announced that Mark Page, a Managing Director at Credit Suisse in New York, will join Macrocure as Chief Financial Officer effective February 10, 2015.
JNJ: 99.53 (+1.13), MCUR: 12.17 (-0.98), DHR: 86.65 (+0.91)
Getinge - A Restructuring Play
Jan Martinek - at Seeking Alpha - Wed Feb 04, 9:02AM CST
Getinge Group Year-End Report 2014
Business Wire - Wed Jan 28, 7:24AM CST
Regulatory News:
Sterilization Technologies - A 2015 Global Market Overview of the $9.5 Billion Market
M2 - Wed Jan 21, 5:35AM CST
Research and Markets (http://www.researchandmarkets.com/research/4j5x5l/sterilization) has announced the addition of the "Sterilization Technologies - A Global Market Overview" report to their offering. Global sterilization market is expected to touch US$5.3 billion 2015 and projected to touch US$9.5 billion in 2020, growing by a CAGR of 12% between 2014 and 2020. Filtration estimated the leading technology for sterilization in 2014 with US$2.7 billion and expected to touch US$3.1 billion 2015 while Medical Devices is the largest application area with market worth US$3 billion in 2014. Growing and aging global population has led to more and more surgeries being performed today than ever before. Therefore, maintaining patient safety assumes extreme criticality in the field of surgery and rules and regulations have to be in place for every aspect of the process for ensuring that errors are averted at all costs. As a consequence, disinfection and sterilization of surgical instruments becomes one area of crucial significance for upholding patient safety. This factor has a direct correlation with an increase in demand for sterilization equipment. Given the fact that every hospital and healthcare facility gives paramount importance to patient safety, sterilization techniques are most widely utilized for medical device applications. This report reviews, analyses and projects the Sterilization technologies market for global and the regional markets including the United States, Europe, Asia-Pacific and Rest of World. Global market for sterilization technologies is projected to touch $9.5 billion by 2020 growing at a decent rate compounded annually at 12% for the period 2014-2020. The United States leads the global market with a share of 29% closely followed by Europe with 27%, during 2014-2020, converting to US$1.4 billion and 1.3 billion respectively in 2014. Worldwide market for sterilization technologies explored in this study includes Chemical Sterilization, Heat Sterilization, Filtration Sterilization and Radiation Sterilization. The report also analyzes the market by application comprising Medical Devices, Pharmaceuticals, Life Sciences and Others. The global market for the above mentioned technologies and applications is analyzed in terms of USD. Key Topics Covered: Part A: Global Market Perspective 1. Introduction 2. Sterilization Applications - A Snapshot 3. Key Market Trends 4. Key Global Players 5. Key Business Trends 6. Global Market Overview Part B: Regional Market Perspective Regional Market Overview 1. The United States 2. Europe 3. Asia-Pacific 4. Rest Of World Part C: Guide To The Industry 1. North America 2. Europe 3. Asia-Pacific 4. Rest Of World Part
Annexure 1. Research Methodology 2. Feedback Executive Summary: - 3M Company - Advanced Sterilization Products - Andersen Products, Inc. - Baumer SA - Belimed AG - Cantel Medical Corp. - Getinge AB - Medline Industries, Inc - Nordion, Inc. - Sakura Seiki Co Ltd - Sterigenics International Inc. - Sterile Technologies, Inc. - Steris Corporation - Synergy Health Plc - TSO3 Inc. - Tuttnauer USA Co Ltd For more information visit http://www.researchandmarkets.com/research/4j...rilization MMM: 154.95 (+1.20), CMN: 54.71 (+1.79)
Getinge: Share Decline On CEO Resignation Presents A Buying Opportunity
Jan Martinek - at Seeking Alpha - Thu Jan 15, 12:33PM CST
Getinge names Alex Myers as new President and CEO
M2 - Tue Jan 13, 4:39AM CST
Medical technology company Getinge AB (STO:GETIB) announced on Monday the appointment of Alex Myers as new president and CEO of the Getinge Group.
Alex Myers Appointed New President and CEO of the Getinge Group
Business Wire - Mon Jan 12, 6:19AM CST
Regulatory News:
